Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Deloitte
US Department of Justice
Accenture
Baxter
Medtronic
Cerilliant
Express Scripts
Fish and Richardson
Citi

Generated: August 16, 2017

DrugPatentWatch Database Preview

LEXXEL Drug Profile

« Back to Dashboard

What is the patent landscape for Lexxel, and what generic Lexxel alternatives are available?

Lexxel is a drug marketed by Astrazeneca and is included in one NDA.

The generic ingredient in LEXXEL is enalapril maleate; felodipine. There are twenty-seven drug master file entries for this compound. Additional details are available on the enalapril maleate; felodipine profile page.

Summary for Tradename: LEXXEL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list85
Patent Applications: see list5
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LEXXEL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LEXXEL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Accenture
Deloitte
Cerilliant
Moodys
Fish and Richardson
Farmers Insurance
UBS
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot